Ragland J D, Censits D M, Gur R C, Glahn D C, Gallacher F, Gur R E
Department of Psychiatry, University of Pennsylvania, Philadelphia 19104-4283, USA.
Psychiatry Res. 1996 Mar 29;60(2-3):135-45. doi: 10.1016/0165-1781(96)02811-9.
The Paired Associate Recognition Test (PART) was developed to measure declarative memory using Wisconsin Card Sorting Test (WCST) stimuli, so that both tasks could be administered during functional neuroimaging to differentiate memory and executive function, and associated frontal and temporal lobe activation in schizophrenia. The current study was designed to compare PART and WCST performance in schizophrenic patients and to examine effects of medication and symptomatology. The PART, WCST, and standard declarative memory tasks were administered to 30 chronic schizophrenic patients and 30 matched healthy control subjects. Supporting task validity was the finding that patients were equally impaired on the PART and the WCST. Neuroleptics did not appear to affect performance. The effect of anticholinergic medication correlated negatively with WCST performance in a small subsample. Severity of schizophrenia-specific symptoms measured at intake on the Brief Psychiatric Rating Scale correlated negatively with performance on the WCST. These results support the application of the PART and WCST in future functional neuroimaging studies.
配对联想识别测试(PART)旨在使用威斯康星卡片分类测试(WCST)的刺激来测量陈述性记忆,以便在功能性神经成像过程中同时进行这两项任务,以区分精神分裂症患者的记忆和执行功能,以及相关的额叶和颞叶激活情况。本研究旨在比较精神分裂症患者在PART和WCST上的表现,并研究药物治疗和症状学的影响。对30名慢性精神分裂症患者和30名匹配的健康对照者进行了PART、WCST和标准陈述性记忆任务测试。支持任务有效性的发现是,患者在PART和WCST上的受损程度相同。抗精神病药物似乎不影响表现。在一个小亚组中,抗胆碱能药物的作用与WCST表现呈负相关。入院时使用简明精神病评定量表测量的精神分裂症特异性症状的严重程度与WCST表现呈负相关。这些结果支持在未来的功能性神经成像研究中应用PART和WCST。